A detailed history of Point72 (Difc) LTD transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 1,385 shares of BHC stock, worth $8,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,385
Holding current value
$8,697
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$5.71 - $8.34 $7,908 - $11,550
1,385 New
1,385 $8.93 Million
Q1 2025

May 15, 2025

BUY
$6.16 - $7.94 $2,186 - $2,818
355 Added 1075.76%
388 $2.52 Million
Q4 2024

Feb 14, 2025

BUY
$7.34 - $9.78 $242 - $322
33 New
33 $264,000
Q1 2024

May 15, 2024

BUY
$7.77 - $10.61 $23,574 - $32,190
3,034 New
3,034 $32.2 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.27B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.